Patent details

EP1079857 Title: Combinatievaccins tegen meningitidis B/C.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1079857
WO Application Number:
US1999011977
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP99926046.6
WO Publication Number:
WO1999061053
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
28/05/1999
Grant date:
29/11/2006
EP Publication Date:
29/11/2006
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/06/2018
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
29/11/2006
EP B1 Publication Date:
29/11/2006
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/05/2019
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
03/05/2017
 
 

 

Name:
The Norwegian Institute of Public Health
Address:
P O Box 4404, 0403 Oslo, Norway (NO)

From:
03/05/2017
 
 

 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

Historical Applicant/holder

From:
01/05/2007
To:
03/05/2017

 

Name:
Novartis Vaccines and Diagnostics, Inc.
Address:
4560 Horton Street, 94608-2916, Emeryville, California, United States of America (US)

From:
01/05/2007
To:
03/05/2017

 

Name:
The Norwegian Institute of Public Health
Address:
P O Box 4404, 0403 Oslo, Norway (NO)

From:
29/11/2006
To:
01/05/2007

 

Name:
Novartis Vaccines and Diagnostics, Inc.
Address:
4560 Horton Street, 94608-2916, Emeryville, California, United States of America (US)

From:
29/11/2006
To:
01/05/2007

 

Name:
Statens Institutt for Folkehelse
Address:
P.O. Box 4404 Torshov, 94608-2916, 0403 Oslo, Norway (NO)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
29/11/2006
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Dan, M. GRANOFF
Address:
CA 94708, Berkeley, United States of America (US)

2

Name:
Ingeborg, S. AABERGE
Address:
N-0403 Oslo, Norway (NO)

3

Name:
Bjorn HANEBERG
Address:
N-0403 Oslo, Norway (NO)

4

Name:
Johan HOLST
Address:
N-0403 Oslo, Norway (NO)

5

Name:
Howard RAFF
Address:
CA 94941, Mill Valley, United States of America (US)

Priority

1

Priority Patent Number:
87351 P
Priority Date:
29/05/1998
Priority Country:
United States of America (US)

2

Priority Patent Number:
106446 P
Priority Date:
30/10/1998
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 39/095;
IPC or IDT classification:
A61K 9/127; A61K 39/385; A61K 39/39;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
01/19
Publication date:
02/01/2019
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
30/17
Publication date:
26/07/2017
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
MED
Journal edition number:
2007/07
Publication date:
02/07/2007
Description:
Other communications

4

Bulletin Heading:
MED
Journal edition number:
2007/07
Publication date:
02/07/2007
Description:
Other communications

5

Bulletin Heading:
EP3
Journal edition number:
2007/05
Publication date:
01/05/2007
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2007/02
Publication date:
01/02/2007
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200648
Publication date:
29/11/2006
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201700993A
Date Registered:
03/05/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

2

Name:
The Norwegian Institute of Public Health
Address:
P O Box 4404, 0403 Oslo, Norway (NO)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
49873-A049873-1
Date Registered:
01/05/2007
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
10/05/2017
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
21/07/2017 Outgoing Correspondence Letter registration deed 2 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_7_151768l118.pdf
03/05/2017 Request for Change First filed deed 3 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_3_rfc20170531112953333.pdf
01/08/2007 Incoming Correspondence Paper Correspondence address details 1 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_2_incomingcorrespondencepaper20070801.pdf
01/08/2007 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_5_incomingcorrespondencepaper20070801.pdf
23/02/2007 Drawings First filed drawings 4 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_0_drawings20070223.pdf
23/02/2007 Incoming Correspondence Paper Incoming Correspondence Paper 1 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_1_incomingcorrespondencepaper20070223.pdf
23/02/2007 Claims Translated claims 2 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_4_claims20070223.pdf
23/02/2007 Incoming Correspondence Paper Correspondence address details 1 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_6_incomingcorrespondencepaper20070223.pdf
23/02/2007 Description Translated description 11 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_9_description20070223.pdf
23/11/2006 Incoming Correspondence Paper Other 1 PDF /6/4/0/6/2/0599926046/docs/ep99926046.6_8_incomingcorrespondencepaper20061123.pdf